Study to Evaluate Darapladib in Moderately Hepatically Impaired Subjects
Clinical trial NCT01154114 · COMPLETED
Trial details
- NCT number
- NCT01154114
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2010-10-15
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.